Chapter 3

Schizoaffective Disorder: Alterations of Neurotransmitters and Neuropeptides in Brain Centers Involved in Psychotic and Affective Symptoms

Felix-Martin Werner and Rafael Coveñas

Abstract

Here, we describe the alterations of classical neurotransmitters and neuropeptides, acting at specific subreceptors, in the brain regions involved in affective and schizophrenic symptoms in the schizoaffective disorder. In schizophrenic symptoms, alterations of the postsynaptic excitatory neurotransmitters dopamine and serotonin and hypoactivity of the presynaptic inhibitory neurotransmitter GABA and of glutamate occur in the mesolimbic system, hippocampus and prefrontal cortex. Neuropeptides, such as neurotensin, cholecystokinin and substance P act as neuromodulators. In depressive symptoms, brain regions such as the brainstem, hypothalamus and hippocampus are involved. Serotonin, dopamine, acetylcholine, GABA and glutamate play an important role. Neuropeptides such as galanin, neuropeptide Y and substance P are involved in the pathophysiology of the affective symptoms. Because schizophrenic and affective symptoms can be enhanced by stressful events or traumatisms, the hypothalamic-adrenal axis and its efferent connections to the brainstem and hippocampus are considered. We suggest additional pharmacotherapies for the treatment of the disease interfering with specific subreceptors of the classical neurotransmitters and neuropeptides described.

Total Pages: 13-36 (24)

Purchase Chapter  Book Details

RELATED BOOKS

.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Alzheimer
.Advances in Alzheimer Research.